Facility
Novavax - Gaithersburg, Maryland
Operated by Novavax Inc. →US
Matrix-M adjuvant R&D and technology hub; supplies Matrix-M to Serum Institute for R21 production; same adjuvant platform as NVX-CoV2373 COVID-19 vaccine
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories